Key result
Treatment of rat hepatocytes with monomethylethanolamine decreased the amount of apoprotein B in the microsomal lumen by approximately 50%, impairing its translocation across the endoplasmic reticulum.
Population
Monolayer cultures of rat hepatocytes
Comparison
Monomethylethanolamine (400 microM overnight) vs Control cells
Design
Preclinical
Follow-up
overnight
Authors
Loading...
Hypothesis-generating for hepatic VLDL pathways; leaves open translation to human dyslipidemia or cardiovascular risk.
Monomethylethanolamine disrupts VLDL secretion by impairing the translocation of apolipoprotein B across the endoplasmic reticulum membrane.
Rusiñol et al. (1993) studied this question. Monomethylethanolamine vs. Control cells was evaluated on Amount of apoproteins B present in the luminal content subfraction of microsomes. Treatment of rat hepatocytes with monomethylethanolamine decreased the amount of apoprotein B in the microsomal lumen by approximately 50%, impairing its translocation across the endoplasmic reticulum.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: